CS logo
small CS logo
Asklepios Fachkliniken München-Gauting

Gauting, Germany
Hospital in Gauting, Bavaria
Robert-Koch-Allee 2, 82131 Gauting

About Asklepios Fachkliniken München-Gauting


"Die Gautinger Lungenklinik ist ein vom Bayerischen Gesundheitsministerium offiziell anerkanntes Lungenzentrum, das überregional besondere Aufgaben in der Behandlung von Lungenerkrankten übernimmt und als Kompetenz- und Koordinierungszentrum andere medizinische Versorger mit gebündelter interdisziplinärer Fachexpertise berät. Mit 268 Betten und jährlich über 10.000 stationär behandelten Patienten ist sie die größte Lungenklinik in Bayern und zählt zu den fünf führenden Lungenkliniken bundesweit. Die Fachklinik ist Lehrkrankenhaus der Ludwig-Maximilians-Universität München und Gründungsmitglied des Comprehensive Pneumology Centers (CPC) sowie eine der wenigen außeruniversitären Lungenkliniken im Deutschen Zentrum für Lungenforschung (DZL)."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
8
Celgene
3
Daiichi Sankyo, Inc.
3
EMD Serono Research & Development Institute, Inc.
3
Janssen Research & Development, LLC
3
AIO-Studien-gGmbH
2
Aeris Therapeutics
2
Amgen
2
BeiGene
2
Boston Scientific Corporation
2
Clovis Oncology, Inc.
2
Total Rows: 30

Clinical Trials at Asklepios Fachkliniken München-Gauting


During the past decade, Asklepios Fachkliniken München-Gauting conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 14 clinical trials were completed, i.e. on average, 36.8% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 8 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years44444422668844660000112233332222Started TrialsCompleted Trails201520162017201820192020202120220510
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
1997-05-01
Unknown status
300
AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy
2007-09-01
2011-05-01
Completed
637
A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer
2007-01-01
2011-02-01
Completed
111
Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
2006-06-01
Unknown status
260
LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer
2008-12-03
2017-11-13
Completed
1,314
CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC)
2009-06-01
2011-12-01
Completed
109
A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung
2011-06-27
2013-11-01
Completed
130
Evaluation of the PneumRx Lung Volume Reduction Coil to Treat Emphysema
2008-01-01
2012-03-01
Completed
36

Rows per page:

1–56 of 56

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Asklepios Fachkliniken München-Gauting" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Celgene" with 3 trials sponsored, "Daiichi Sankyo, Inc." with 3 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 30 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Asklepios Fachkliniken München-Gauting" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "PneumRx, Inc." with 2 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 12 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 8Hoffmann-La Roche: 8Celgene: 3Celgene: 3Daiichi Sankyo, Inc.: 3Daiichi Sankyo, Inc.: 3EMD Serono Research &Development Institute,Inc.: 3EMD Serono Research &Development Institute,Inc.: 3Janssen Research &Development, LLC: 3Janssen Research &Development, LLC: 3AIO-Studien-gGmbH: 2AIO-Studien-gGmbH: 2Aeris Therapeutics: 2Aeris Therapeutics: 2Amgen: 2Amgen: 2BeiGene: 2BeiGene: 2Boston Scientific Corporation: 2Boston Scientific Corporation: 2

Created with Highcharts 11.1.0Top CollaboratorsMerck KGaA,Darmstadt, Germany: 3Merck KGaA,Darmstadt, Germany: 3AstraZeneca: 2AstraZeneca: 2Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2Eli Lilly and Company: 2Eli Lilly and Company: 2PneumRx, Inc.: 2PneumRx, Inc.: 2Roche Pharma AG: 2Roche Pharma AG: 2Amgen: 1Amgen: 1Asklepios KlinikenHamburg GmbH: 1Asklepios KlinikenHamburg GmbH: 1BeiGene: 1BeiGene: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1

Clinical Trials Conditions at Asklepios Fachkliniken München-Gauting


According to Clinical.Site data, the most researched conditions in "Asklepios Fachkliniken München-Gauting" are "Non-Small Cell Lung Cancer" (9 trials), "Non-small Cell Lung Cancer" (8 trials), "Carcinoma, Non-Small-Cell Lung" (6 trials), "Emphysema" (2 trials) and "Pulmonary Emphysema" (2 trials). Many other conditions were trialed in "Asklepios Fachkliniken München-Gauting" in a lesser frequency.

Clinical Trials Intervention Types at Asklepios Fachkliniken München-Gauting


Most popular intervention types in "Asklepios Fachkliniken München-Gauting" are "Drug" (51 trials), "Device" (5 trials), "Other" (5 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (17 trials), "Pemetrexed" (10 trials), "Placebo" (10 trials), "Atezolizumab" (7 trials) and "Cisplatin" (7 trials). Other intervention names were less common.

Clinical Trials Genders at Asklepios Fachkliniken München-Gauting


The vast majority of trials in "Asklepios Fachkliniken München-Gauting" are 56 trials for "All" genders.

Clinical Trials Status at Asklepios Fachkliniken München-Gauting


Currently, there are NaN active trials in "Asklepios Fachkliniken München-Gauting". undefined are not yet recruiting, 13 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Asklepios Fachkliniken München-Gauting, undefined suspended trials, and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Asklepios Fachkliniken München-Gauting, 3 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 32Phase 3: 32Phase 2: 20Phase 2: 20Phase 1: 3Phase 1: 3Phase 4: 2Phase 4: 2Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 18Completed: 18Active, not recruiting: 14Active, not recruiting: 14Recruiting: 13Recruiting: 13Terminated: 7Terminated: 7Unknown status: 3Unknown status: 3Withdrawn: 1Withdrawn: 1